Last news
MaxsMaking Inc. Announces Receipt of Nasdaq Delisting Determination Notice

MaxsMaking Inc. Announces Receipt of Nasdaq Delisting Determination Notice

SHANGHAI, July 24, 2026 /PRNewswire/ -- MaxsMaking Inc. (Nasdaq: MAMK) ("MaxsMaking" or the "Company"), a manufacturer of customized consumer goods with a focus on advanced technology and innovation, today announced that it received a Staff...

LG INSTAVIEW™ REFRIGERATOR SURPASSES 5.3 MILLION IN GLOBAL SALES

LG INSTAVIEW™ REFRIGERATOR SURPASSES 5.3 MILLION IN GLOBAL SALES

Chosen by Customers Worldwide, LG's Instaview Refrigerator Innovation Continues to Redefine the Kitchen Experience a Decade After Its Debut News Summary LG Electronics' InstaView™ refrigerator celebrates the 10th anniversary of its 2016 launch by...

Laminar Pharma Announces "Last Patient, Last Visit" in LAM561 Phase 2b/3 Trial for Newly Diagnosed Glioblastoma Patients

Laminar Pharma Announces "Last Patient, Last Visit" in LAM561 Phase 2b/3 Trial for Newly Diagnosed Glioblastoma Patients

PALMA DE MALLORCA, Spain, July 24, 2026 /PRNewswire/ -- Laminar Pharma, a leader in the development of innovative therapies based on a novel membrane lipid therapy approach, today announced that the last patient has completed their last visit (LPLV)...

Agoda Reveals Growing Travel Interest Ahead of Japan's Summer 2026 Fireworks Festivals

Agoda Reveals Growing Travel Interest Ahead of Japan's Summer 2026 Fireworks Festivals

― Searches for Nagaoka during the Nagaoka Festival Grand Fireworks up 50x, as interest in "fireworks travel" expands nationwide ― SINGAPORE, July 24, 2026 /PRNewswire/ -- Agoda Company Pte. Ltd. (Headquarters: Singapore; CEO: Omri Morgenshtern),...

ArkBio Completes all Cohort Dosing in Australian Phase I Trial with Influenza AFC Drug AK0406

ArkBio Completes all Cohort Dosing in Australian Phase I Trial with Influenza AFC Drug AK0406

SHANGHAI, July 24, 2026 /PRNewswire/ -- Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") today announced that all cohorts of healthy volunteers have been dosed in an Australian Phase I trial with AK0406, a novel long-acting antiviral-Fc conjugate...

HD Korea Shipbuilding & Offshore Engineering Pursues AI-Driven Transformation of Shipbuilding Industry

HD Korea Shipbuilding & Offshore Engineering Pursues AI-Driven Transformation of Shipbuilding Industry

HD Korea Shipbuilding & Offshore Engineering signs definitive agreement with Siemens to implement next-generation marine platform and establish a 3D single-data platform Aims to build an autonomous manufacturing system that digitally connects...

JAMS Launches AI for Enterprise Job Scheduling: JAX and JAMS MCP

JAMS Launches AI for Enterprise Job Scheduling: JAX and JAMS MCP

A new AI agent and an open-standard connector let IT teams query, diagnose, and manage automation in plain language, on the model they choose, with operational data able to stay onshore inside their own network SYDNEY, July 24, 2026 /PRNewswire/ --...

Harbour BioMed Announces Positive Profit Alert for 2026 Interim Results, Marking Seventh Consecutive Profitable Half-Year as Platform-Based Advantages Drive Sustainable Growth

Harbour BioMed Announces Positive Profit Alert for 2026 Interim Results, Marking Seventh Consecutive Profitable Half-Year as Platform-Based Advantages Drive Sustainable Growth

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, July 24, 2026 /PRNewswire/ -- Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company focused on the discovery and development of novel antibody therapeutics in...

1 2 3 4 5 6 7 8 9 10 ... 5089
menu
menu